AA
IBBJ

AlphaMark Advisors’s Defiance Nasdaq Junior Biotechnology ETF IBBJ Stock Holding History

AlphaMark Advisors’s Portfolio IBBJ Stock Details IBBJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-400
Closed -$12K – 627
2021
Q3 		$12K Hold
400
– – ﹤0.01% 387
2021
Q2 		$13K Hold
400
– – ﹤0.01% 380
2021
Q1 		$13K Buy
+400
New +$14.5K 0.01% 371

AlphaMark Advisors's IBBJ Position: Q4 2021 in Review

AlphaMark Advisors sold out of Defiance Nasdaq Junior Biotechnology ETF (IBBJ) in Q4 2021, closing a stake of 400 shares — an estimated $12K sold.

AlphaMark Advisors first reported a position in IBBJ in Q1 2021 and held it in 3 quarters. The position peaked at $13K in Q2 2021. 0 funds tracked by Wall St. Rank hold IBBJ as of Q4 2021.

  • AlphaMark Advisors reported no remaining Defiance Nasdaq Junior Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
  • AlphaMark Advisors sold 400 Defiance Nasdaq Junior Biotechnology ETF shares in Q4 2021, an estimated $12K.
  • AlphaMark Advisors first reported a position in Defiance Nasdaq Junior Biotechnology ETF in Q1 2021 and held it in 3 quarters.
  • AlphaMark Advisors's Defiance Nasdaq Junior Biotechnology ETF position peaked at $13K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Defiance Nasdaq Junior Biotechnology ETF as of Q4 2021.

Based on AlphaMark Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.